Amyris (AMRS)

Trade AMRS now with
2/5/2019 8:10:04 AM Amyris Announces $255 Mln Cannabinoid Development, Licensing And Commercialization Agreement
12/31/2018 8:32:12 AM Amyris Inks Long-term Agreement With Xinfu Of China
12/7/2018 8:38:44 AM Amyris Reports Sale Of $60 Mln Of Unsecured Convertible Senior Notes In Private Placement
12/3/2018 7:17:36 AM Amyris Announces New Partnership With Camil Alimentos
11/30/2018 8:58:28 AM Amyris Plans Introduction Of New Tabletop Sweetener Application Developed In Collaboration With Givaudan
11/8/2018 8:34:58 AM Amyris Further Expands Original Collaboration With Yifan Pharmaceutical
9/27/2018 8:34:25 AM Amyris Enters Into Extensive Collaboration Agreement With Yifan Pharma
8/30/2018 8:33:05 AM Amyris Gets Green Light For Commercial Sales Of Its New, Natural, Zero-Calorie Sweetener
8/17/2018 9:04:29 AM Amyris Reports Pricing Of Secondary Offering Of 7.65 Mln Shares By Certain Of Existing Stockholders At $6.25/Shr
7/2/2018 8:33:31 AM Amyris Closes On A $36 Mln Term Loan With Great American Capital Partners, LLC
6/26/2018 8:35:20 AM Amyris And BGI Agree To JV To Develop Products To Improve Human Health In Greater China
6/12/2018 8:47:01 AM Amyris Executes Agreement For A Significant Project Consortium In Europe
5/18/2018 8:31:28 AM Amyris JV Company, Novvi, And Chevron Enter Agreement To Develop And Bring To Market New Renewable Base Oil Tech
5/3/2018 8:36:10 AM Amyris Partners With Fragrance Partner, Firmenich, To Support Development, Commercialization Of Z11
1/25/2018 2:17:32 PM B. Riley FBR Initiates Amyris (AMRS) At Buy With $8 Price Target
8/1/2012 8:25:25 AM Robert W. Baird Reiterates Amyris (AMRS) At Neutral With $2 Price Target